Shell Increases Codexis Stake
Royal Dutch Shell has increased its equity stake in Codexis Inc., a developer of industrial biocatalysts, including enzymes and microbes. No financial terms were disclosed for the deal, which was part of a larger strategic arrangement. Codexis last year canceled plans for a $100 million IPO. At the time, it had raised over $80 million from CCTV Investments, CMEA Ventures, Pequot Capital, Pfizer, Maxygen and Bio*One Capital.
11 March 2009•3 mins read
